ANIK Anika Therapeutics RESULTS: Q2, Q2 REV $32.61M, Q2 pretax profit $3.38M, Q2 gross profit $21.244M, Q2 Income from operations $2.954M, Q
ANIK Anika Therapeutics RESULTS: Q2, Q2 REV $32.61M, Q2 pretax profit $3.38M, Q2 gross profit $21.244M, Q2 Income from operations $2.954M, Q2 Net Income $3.309M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.